SCOPUS 정보 검색 플랫폼

Parkinsonism and Related Disorders

Volumn 11, Issue 5, 2005, Pages 333-334

The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease [1]

(2) Tousi, Babak a Subramanian, Thyagarajan a

a LERNER RESEARCH INSTITUTE (United States)

Author keywords

Dyskinesia; Levetiracetam; Levodopa induced dyskinesia; Parkinson's disease

Indexed keywords

AMANTADINE; BUSPIRONE; CARBIDOPA PLUS LEVODOPA; CLOZAPINE; ENTACAPONE; ETIRACETAM; FLUOXETINE; LEVODOPA; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE;

ADD ON THERAPY; ADULT; AGED; ANAMNESIS; BRAIN DEPTH STIMULATION; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFECT; DYSKINESIA; FEMALE; HUMAN; LETTER; MALE; MEDICAL ASSESSMENT; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; SOMNOLENCE; TREATMENT OUTCOME;

AGED; ANTICONVULSANTS; ANTIPARKINSON AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PIRACETAM;

EID: 22144443869 PISSN: 13538020 EISSN: None Source Type: Journal
DOI: 10.1016/j.parkreldis.2004.11.003 Document Type: Letter

Times cited : (18)

References (7)

1
- 0036229721
- How common are complications of Parkinson's disease
- A. Schrag, Y. Ben-Shlomo, and N. Quinn How common are complications of Parkinson's disease J Neurol 249 2002 419 423
- (2002) J Neurol , vol.249 , pp. 419-423
- Schrag, A.¹ Ben-Shlomo, Y.² Quinn, N.³

2
- 1642538376
- Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque
- E. Bezard, M.P. Hill, A.R. Crossman, J.M. Brotchie, A. Michel, R. Grimee, and H. Klitgaard Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque Eur J Pharmacol 485 1-3 2004 159 164
- (2004) Eur J Pharmacol , vol.485 , Issue.1-3 , pp. 159-164
- Bezard, E.¹ Hill, M.P.² Crossman, A.R.³ Brotchie, J.M.⁴ Michel, A.⁵ Grimee, R.⁶ Klitgaard, H.⁷

3
- 0033800837
- Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs
- D.G. Margineanu, and H. Klitgaard Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs Pharmacol Res 42 4 2000 281 285
- (2000) Pharmacol Res , vol.42 , Issue.4 , pp. 281-285
- Margineanu, D.G.¹ Klitgaard, H.²

4
- 0035987775
- The antiepileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents
- J.M. Rigo, G. Hans, L. Nguyen, V. Rocher, S. Belachew, B. Malgrange, P. Leprince, G. Moonen, I. Selak, A. Matague, and H. Klitgaard The antiepileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents Br J Pharmacol 136 2002 659 672
- (2002) Br J Pharmacol , vol.136 , pp. 659-672
- Rigo, J.M.¹ Hans, G.² Nguyen, L.³ Rocher, V.⁴ Belachew, S.⁵ Malgrange, B.⁶ Leprince, P.⁷ Moonen, G.⁸ Selak, I.⁹ Matague, A.¹⁰ Klitgaard, H.¹¹

5
- 3042748137
- The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
- B.A. Lynch, N. Lambeng, K. Nocka, P. Kensel-Hammes, S.M. Bajjalieh, A. Matagne, and B. Fuks The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc Natl Acad Sci USA 101 26 2004 9861 9866
- (2004) Proc Natl Acad Sci USA , vol.101 , Issue.26 , pp. 9861-9866
- Lynch, B.A.¹ Lambeng, N.² Nocka, K.³ Kensel-Hammes, P.⁴ Bajjalieh, S.M.⁵ Matagne, A.⁶ Fuks, B.⁷

6
- 1342326299
- Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by l-dopa and ropinirole in the MPTP-lesioned marmoset
- M.P. Hill, E. Bezard, S.G. McGuire, A.R. Crossman, J.M. Brotchie, A. Michel, R. Grimee, and H. Klitgaard Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by l-dopa and ropinirole in the MPTP-lesioned marmoset Mov Disord 18 11 2003 1301 1305
- (2003) Mov Disord , vol.18 , Issue.11 , pp. 1301-1305
- Hill, M.P.¹ Bezard, E.² McGuire, S.G.³ Crossman, A.R.⁴ Brotchie, J.M.⁵ Michel, A.⁶ Grimee, R.⁷ Klitgaard, H.⁸

7
- 3042637096
- Levetiracetam potentiates the anti-dyskinetic action of amantadine in the MPTP-lesioned primate model of Parkinson's disease
- 31091
- M.P. Hill, P. Ravenscroft, E. Bezard, A.R. Crossman, J.M. Brotchie, A. Michel, R. Grimee, and H. Klitgaard Levetiracetam potentiates the anti-dyskinetic action of amantadine in the MPTP-lesioned primate model of Parkinson's disease J Pharmacol Exp Ther 31091 2004 386 394
- (2004) J Pharmacol Exp Ther , pp. 386-394
- Hill, M.P.¹ Ravenscroft, P.² Bezard, E.³ Crossman, A.R.⁴ Brotchie, J.M.⁵ Michel, A.⁶ Grimee, R.⁷ Klitgaard, H.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.